Annual Current Assets
$207.55 M
-$47.82 M-18.72%
December 31, 2023
Summary
- As of February 7, 2025, ADAP annual total current assets is $207.55 million, with the most recent change of -$47.82 million (-18.72%) on December 31, 2023.
- During the last 3 years, ADAP annual current assets has fallen by -$190.60 million (-47.87%).
- ADAP annual current assets is now -50.04% below its all-time high of $415.46 million, reached on December 31, 2021.
Performance
ADAP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$244.21 M
-$9.56 M-3.77%
September 30, 2024
Summary
- As of February 7, 2025, ADAP quarterly total current assets is $244.21 million, with the most recent change of -$9.56 million (-3.77%) on September 30, 2024.
- Over the past year, ADAP quarterly current assets has increased by +$57.31 million (+30.66%).
- ADAP quarterly current assets is now -46.69% below its all-time high of $458.09 million, reached on June 30, 2020.
Performance
ADAP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ADAP Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.7% | +30.7% |
| 3 y3 years | -47.9% | -18.7% |
| 5 y5 years | -10.2% | +66.2% |
ADAP Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.0% | at low | -41.2% | +30.7% |
| 5 y | 5-year | -50.0% | +72.3% | -46.7% | +102.7% |
| alltime | all time | -50.0% | >+9999.0% | -46.7% | +351.5% |
Adaptimmune Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $244.21 M(-3.8%) |
| Jun 2024 | - | $253.77 M(+35.8%) |
| Mar 2024 | - | $186.90 M(-9.9%) |
| Dec 2023 | $75.06 M(+2.1%) | $207.55 M(-5.4%) |
| Sep 2023 | - | $219.37 M(-16.2%) |
| Jun 2023 | - | $261.77 M(+22.5%) |
| Mar 2023 | - | $213.75 M(-16.3%) |
| Dec 2022 | $73.55 M(+36.0%) | $255.37 M(-3.3%) |
| Sep 2022 | - | $264.14 M(-17.8%) |
| Jun 2022 | - | $321.17 M(-10.7%) |
| Mar 2022 | - | $359.46 M(-13.5%) |
| Dec 2021 | $54.09 M(+2.1%) | $415.46 M(+38.3%) |
| Sep 2021 | - | $300.45 M(-10.9%) |
| Jun 2021 | - | $337.34 M(-6.1%) |
| Mar 2021 | - | $359.29 M(-9.8%) |
| Dec 2020 | $52.99 M(-13.2%) | $398.15 M(-6.7%) |
| Sep 2020 | - | $426.73 M(-6.8%) |
| Jun 2020 | - | $458.09 M(+101.1%) |
| Mar 2020 | - | $227.76 M(+89.0%) |
| Dec 2019 | $61.05 M | $120.49 M(-18.0%) |
| Sep 2019 | - | $146.97 M(-16.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $175.13 M(-12.6%) |
| Mar 2019 | - | $200.30 M(-13.3%) |
| Dec 2018 | $45.64 M(-10.4%) | $231.09 M(-11.7%) |
| Sep 2018 | - | $261.61 M(+61.8%) |
| Jun 2018 | - | $161.65 M(-17.4%) |
| Mar 2018 | - | $195.66 M(-15.0%) |
| Dec 2017 | $50.96 M(+42.5%) | $230.18 M(-9.3%) |
| Sep 2017 | - | $253.90 M(+6.8%) |
| Jun 2017 | - | $237.74 M(+6.6%) |
| Mar 2017 | - | $222.93 M(+12.2%) |
| Dec 2016 | $35.76 M(+57.0%) | $198.75 M(-0.4%) |
| Sep 2016 | - | $199.54 M(-8.5%) |
| Jun 2016 | - | $218.18 M(-8.5%) |
| Mar 2016 | - | $238.56 M(-15.6%) |
| Dec 2015 | $22.77 M(+308.8%) | - |
| Sep 2015 | - | $282.56 M(+109.5%) |
| Jun 2015 | $5.57 M(+289.4%) | - |
| Dec 2014 | - | $134.87 M(+149.4%) |
| Jun 2014 | $1.43 M(+586.8%) | $54.09 M |
| Jun 2013 | $208.30 K(+113.9%) | - |
| Jun 2012 | $97.40 K | - |
FAQ
- What is Adaptimmune Therapeutics annual total current assets?
- What is the all time high annual current assets for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual current assets year-on-year change?
- What is Adaptimmune Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly current assets year-on-year change?
What is Adaptimmune Therapeutics annual total current assets?
The current annual current assets of ADAP is $207.55 M
What is the all time high annual current assets for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual total current assets is $415.46 M
What is Adaptimmune Therapeutics annual current assets year-on-year change?
Over the past year, ADAP annual total current assets has changed by -$47.82 M (-18.72%)
What is Adaptimmune Therapeutics quarterly total current assets?
The current quarterly current assets of ADAP is $244.21 M
What is the all time high quarterly current assets for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly total current assets is $458.09 M
What is Adaptimmune Therapeutics quarterly current assets year-on-year change?
Over the past year, ADAP quarterly total current assets has changed by +$57.31 M (+30.66%)